focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I wonder if the drop is the mms trying to accumalate some extra shares. Well hoping anyway.
Must admit I expected a continued rise towards the end of the month.
Developing diabetes during/post covid seems quite common. 3 of my colleagues have done so . I know steroids which are used in treatment effect blood sugars but it seems to be part of the virus as their symptoms have continued and required intervention.
Steptoe I ment the rise back from the 70s during week. I know its not much of one. I used to work for Specsavers many years ago.
Don't know how long before we would hear about if successful for UK-CTAP. By AGM to early I would think but wonder if rise will continue into next week.
2.81 on Nasdaq now.
Buys going to negotiated on Halifax but now has just ticked up. Counting down the days!
Torreagus creeping up again now so you should be back even. I am sure anyone buying at these levels will be rewarded. Its people like me who brought in at 6-7+ that will have to wait. I know there has been a opertunity to buy and average down but sometimes those doubting scars do not heal that quick.
Lots of new posters over last few days pushing price up. Back to same old names who have been here a while today so I am sure some trading been occuring backed by RNS the other day that was not overly exciting. Only guessing.
This is the ongoing problem and something I feel LTH have issues with. Don't doubt the potential of our products and the Science but at times the buisness ability and comunication from the board. This will be what is needed to continue our climb back to a more reasonable valuation level.
Expected a bit more of a continued rise after last week.
Could be with anticipation of news start of next week.
You can buy 25000000 in one go on Halifax.
Pingu I agree. It is with those thoughts I am happy to move on from the Mint disaster and now hope we start to get some actual product related RNS's so we can again concentrate on what we are potentially bringing to market.